MDREX JAPAN, as the Japanese branch of MDREX Korea, ensures that Korean client companies’ products and services are successfully provides total solutions to help Korean client companies successfully enter the Japanese market with their products and services.
Japan’s medical device market ranks as the third largest in the world, and with the accelerating aging population, interest in medical services as well as beauty and wellness sectors is increasing. However, Japan operates a strict approval system centered on the PMDA (Pharmaceuticals and Medical Devices Agency), and in combination with the rigorous insurance procedures of the Ministry of Health, Labour and Welfare, sufficient clinical evidence and a systematic regulatory strategy are essential for introducing new products.
For these reasons, MDREX established its Japanese branch (MDREX JAPAN) and, through collaboration with local partners, provides domestic medical device companies with the most effective approaches and solutions regarding relevant regulations for entering the Japanese market.
MDREX JAPAN is an organization that provides comprehensive consulting and execution support for all stages of entering the Japanese medical device market, covering the full cycle from product approval to insurance listing, quality management, clinical trials, and post-market surveillance.
We systematically support regulatory and insurance strategies, including handling PMDA approval and certification processes, performing DMAH/MAH roles, GMP certification, new medical technology evaluations, and the health insurance reimbursement rates.
Additionally, we serve as a strategic partner by covering market analysis, distribution strategy, clinical trial management, and post-market safety surveillance. Leveraging local networks and strengthening communication between the global headquarters and the Japanese market, we support the stable entry and dissemination of innovative medical devices and new technology products in Japan.
